AtaiBeckley (ATAI) Amortizatization of Intangibles (2020 - 2025)
AtaiBeckley (ATAI) posted quarterly Amortizatization of Intangibles of $149000.0 for Q1 2025.
Analysis
AtaiBeckley (ATAI) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
AtaiBeckley has reported Amortizatization of Intangibles for 6 years, with the latest figure at $27000.0 in Q2 2025.
- Quarterly Amortizatization of Intangibles fell 72.45% year-over-year to $27000.0 in Q2 2025, while the trailing twelve-month figure through Sep 2025 was $364000.0 (down 14.55% YoY) and the FY2024 annual result came in at $515000.0, up 38.81% from the prior year.
- Amortizatization of Intangibles for Q1 2025 stood at $149000.0.
- Over five years, Amortizatization of Intangibles peaked at $93.0 billion in Q2 2021 and troughed at -$8000.0 in Q3 2021.
- A 5-year average of $6.2 billion and a median of $98000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles tumbled 140.0% in 2021, then jumped 4266.67% in 2022.
- Over 5 years, Amortizatization of Intangibles stood at $3000.0 in 2021, then surged by 4266.67% to $131000.0 in 2022, then decreased by 24.43% to $99000.0 in 2023, then surged by 89.9% to $188000.0 in 2024, then slumped by 85.64% to $27000.0 in 2025.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $27000.0, $149000.0, and $188000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 188,000.00 |
| Sep 30, 2024 | 131,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 99,000.00 |
| Jun 30, 2023 | 91,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Dec 31, 2021 | -5,000.00 |
| Jun 30, 2021 | 93.00 Bn |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | 20,000.00 |